Urologic & Prostate Cancer
About Prostate Cancer
What is Prostate Cancer?
Prostate cancer is the most common malignancy (other than skin cancer) diagnosed in American men.
It has the potential to grow and spread quickly, but for most men it is a relatively slow growing disease.
It is important for patients to discuss with their doctors the various aspects of their particular type of prostate cancer to understand how aggressive it is and how best to treat it.
Download Dr. Hsi's prostate cancer guide
What are the Symptoms of Prostate Cancer?
Prostate cancer will not always present symptoms. For men that do experience symptoms, these could include:
- Urinary problems – difficulty urinating, frequent urination, pain or burning urination
- Blood – in urine or semen
- Pain – hips, pelvis, spine or upper legs
- Pain or discomfort – during urination or ejaculation
How is Prostate Cancer Diagnosed?
Currently, the best way to diagnose prostate cancer is through screening, which is done as part of a routine annual examination by your primary care doctor.
The main screening tools for prostate cancer detection are the digital rectal exam and the prostate specific antigen (PSA) blood test.
If either or both of these tests are abnormal, other tests may be ordered.
What are Prostate Cancer Treatment Options?
The treatment of prostate cancer depends upon:
- the type of cancer
- whether or not the cancer has spread (metastasized)
- patient’s age
- patient's general health status
- prior prostate treatments
There are three standard therapies for men with organ-confined prostate cancer:
Active surveillance may be recommended only if a cancer is not causing any symptoms and is expected to grow very slowly.
This approach is suited for men who are older or have other serious health problems. Because some prostate cancers spread very slowly, they may never require treatment.
Other men choose active surveillance because they feel the side effects of treatment outweigh the benefits.
The prostate cancer is regularly and carefully monitored with PSA testing, clinical evaluation and prostate biopsies to ensure that the cancer is not becoming more aggressive.
Surgery (radical prostatectomy)
Surgical treatment for prostate cancer involves removing the entire prostate as well as the seminal vesicles, a procedure called radical prostatectomy.
If the cancer is confined within the tissues removed at surgery, the surgical procedure alone can successfully cure localized prostate cancer.
After surgery, the PSA level in the blood should decrease to undetectable levels or detect even small amounts of residual cancer.
Radiation therapy (brachytherapy)
Brachytherapy involves placing radioactive seeds in or near tumors in the prostate, which work alone or in combination with external beam radiation.
Which Prostate Cancer Treatment is Best for Me?
The best treatment for your prostate cancer depends on a number of factors.
It is important to consult both urologic surgeons and radiation oncologists to get the best recommendation.
Different Types of Prostate Cancer Screening
Digital Rectal Exam (DRE)
For this test, the doctor inserts a gloved and lubricated finger into the rectum.
This allows the doctor to feel the back portion of the prostate gland for size, and any irregular or firm areas.
It is not accurate at detecting prostate cancer that is situated deep within the gland or is very small.
Prostate Specific Antigen (PSA)
PSA is a protein produced by both normal and cancerous cells in the prostate.
Growth of prostate cancer cells as well as other conditions such as benign enlargement of the prostate (BPH) or inflammation/infection (prostatitis) can cause an elevation of the PSA level in the blood.
The normal range of PSA is generally considered to be between zero and four nanograms of PSA per milliliter (ng/mL) of blood.
If the results of the PSA blood test are above the normal range, or the level has increased rapidly from the last test, the doctor may recommend further testing and possibly a biopsy.
It should be noted that men can be diagnosed with prostate cancer even with a PSA in the normal range. In one large study, about 15 percent of men diagnosed with prostate cancer did indeed have a PSA in the normal range.
The percent-free PSA is a blood test that compares the amount of PSA bound to proteins in the blood to the amount of PSA that circulates by itself (unbound).
When the percent-free PSA is found to be less than 25 percent, prostate cancer is more likely to be present.
The lower the percentage, the more likely prostate cancer is present. This test can be useful when the standard PSA test is at or just over the high end of the normal range.
PCA3Plus® is a urine test that detects a specific gene called PCA3, which is highly expressed in prostate cancer cells.
For this test, the doctor will perform a digital rectal exam and massage the prostate to induce the shedding of prostate cells into the urine.
A urine sample is then collected and sent to a laboratory to obtain a PCA3 score.
The higher the score, the more likely a biopsy will be positive for prostate cancer. This test is available in the United States, but it is not yet FDA approved.
Transrectal ultrasound (TRUS) is a specific ultrasound test that uses a probe inserted into the rectum to visualize the prostate gland.
It can be used to measure the size of the gland, detect anatomic variations and sometimes detect abnormal tissue.
Needle biopsies of the prostate are usually done under TRUS guidance. A urologist usually performs these procedures in the office by placing the patient on his side and inserting the ultrasound probe into the rectum.
Needles are pushed alongside the ultrasound probe through the rectal wall and into the prostate to sample the tissue. Usually 10-12 biopsies are taken covering the entire gland.
A newer technique called transperineal saturation biopsy is also done under TRUS guidance.
This procedure is usually done under anesthesia, and needles are placed through the skin between the rectum and scrotum (perineum) and into the prostate gland.
Up to 24 or more biopsies can be obtained using this technique.
Areas that are difficult to access using the transrectal approach can be reached using the transperineal technique.
Transperineal saturation biopsy is often done if a prior transrectal biopsy is negative, but other tests, such as PSA, indicate a high likelihood of cancer.
Based on the screening test results, a biopsy may be recommended and performed as described using transrectal ultrasound guidance.
A pathologist will then examine the tissue samples under a microscope to determine whether or not the prostate contains cancerous tissue.
The biopsy can also give important indications as to how extensive the cancer is within the prostate by number of cores that are positive for cancer.